WIHI - A Podcast from the Institute for Healthcare Improvement

Date: September 13, 2018 Featuring: Nicole Brandt, PharmD, MBA, BCGP, BCPP, FASCP, Executive Director, Peter Lamy Center on Drug Therapy and Aging; Professor, University of Maryland School of Pharmacy  Florian Daragjati, PharmD, BCPS, Director, Ascension Center of Excellence for Antimicrobial Stewardship and Infection Prevention Lynn Deguzman, PharmD, BCGP, Regional Clinical Operations Manager, Kaiser Permanente Leslie J. Pelton, MPA, Senior Director, Institute for Healthcare Improvement Leanne Phillips, PharmD, BCPS, Clinical Pharmacy Coordinator, St. Vincent’s East, Ascension The ground is shifting for prescription medication in the US and Canada, and in other countries, too. There’s much talk and publicity about weaning people off drugs, or what is referred to as “deprescribing”: a process that entails taking patients off some of their medications or tapering down the dosages. The underlying reasons for deprescribing include concerns about polypharmacy, especially the impact on older and frail adu